The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus
Abstract
TREX1 acts in concert with the SET complex in granzyme A-mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutières syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P = 4.1 x 10(-7)). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [115]
Citations
Cites
Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.003 · Cited by 1,008
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789
Mutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470
Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513443 · Cited by 410
Self-citationMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380
Mendell, J. T., & Dietz, H. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00583-9 · Cited by 289
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Mazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citation
Cited by
Items 501–600 of 728
Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection
Sironi, M., Biasin, M., Forni, D., Cagliani, R., Luca, M. D., Saulle, I., Caputo, S. L., Mazzotta, F., Macías, J., Pineda, J. A., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328354b3c2 · Cited by 11
Cytokines and Interferons in Lupus
Crow, M. K., Niewold, T. B., & Kirou, K. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00007-8 · Cited by 7
Xie, N., Sun, Q., Yang, J., Zhou, Y., Xu, H., Zhou, Y., & Zhou, Y. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01712-9 · Cited by 8
Singh, G., Agarwal, A. K., Prosek, J. M., et al. (2017) · Lupus · doi:10.1177/0961203316688783 · Cited by 7
Gagne, S. J., Sivaraman, V., & Akoghlanian, S. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1169638 · Cited by 6
“Glomerulonephritis is reported with unclear frequency and is often partially responsive to conventional immunosuppressive medications (60).”
BackgroundJin, Z., Zhang, Y., Luo, X., Geng, M., Duan, W., Xie, Z., & Zhang, H. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10860-6 · Cited by 6
“Trex1 deficiency has also been reported in systemic lupus erythematosus (SLE) patients [21, 22].”
Thuner, J., Cognard, J., & Bélot, A. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101962 · Cited by 7
UV-induzierte Pathogenese des Lupus erythematodes
Kurz, B., Klein, B., Berneburg, M., & Meller, S. (2024) · Die Dermatologie · doi:10.1007/s00105-024-05369-w · Cited by 8
Guillet, S., Lazarov, T., Jordan, N., Boisson, B., Tello‐Lafoz, M., Craddock, B. P., Zhou, T., Nishi, C., Bareja, R., Yang, H., et al. (2024) · eLife · doi:10.7554/elife.96085.3 · Cited by 7
cGMP-AMP synthase paves the way to autoimmunity
Rodero, M. P., & Crow, Y. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517578112 · Cited by 8
Jordan, N., & D’Cruz, D. P. (2015) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x15601805 · Cited by 9
“Furthermore, there is a strong link between monogenic causes of SLE and interferonopathies such as Aicardi–Goutieres syndrome [Lee-Kirsch et al. 2007; Rice et al. 2013, 2014].”
BackgroundAn Epigenetics-Based Hypothesis of Autoantigen Development in Systemic Lupus Erythematosus
Brooks, W. H. (2020) · Epigenomes · doi:10.3390/epigenomes4020006 · Cited by 5
Endo, Y., Koga, T., Otaki, H., Furukawa, K., & Kawakami, A. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108732 · Cited by 6
Wu, Y., Xiao, N., Li, Y., Gao, Q., Ning, Y., Yu, L. M., Cai, Y., Pan, C., Zhang, X., Huang, N., et al. (2021) · Molecular Breeding · doi:10.1007/s11032-021-01268-3 · Cited by 6
Migraine and Neurogenetic Disorders
Sathe, S. A. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0360-9 · Cited by 6
“Mutations in TREX1 have been identified in several inherited and acquired auto-immune related diseases, such as Aicardi-Goutieres syndrome [50, 51], familial chilblain lupus [51, 52], and systemic lupus erthyematosus (SLE) [53].”
BackgroundUnderstanding Lupus: Fishing Genes Out of Mice and Men
Vyse, T. J. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.007 · Cited by 6
“In humans, rare more penetrant mutations have been identified, such as complement C1q-deficiency and more recently mutations in the exonuclease TREX1 (Lee-Kirsch et al., 2007) (Figure 1).”
BackgroundSelf-citationFamiliärer Chilblain-Lupus: Typ-I-Interferonopathie mit Modellcharakter
Fiehn, C. (2017) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-017-0285-5 · Cited by 6
A Case of TREX1-Associated Retinal Vasculopathy with Cerebral Leukodystrophy
Thomas, A. S., & Lin, P. (2019) · Ophthalmology Retina · doi:10.1016/j.oret.2019.07.014 · Cited by 6
Østergaard, E., Joensen, F., Sundberg, K., Dunø, M., Hansen, F. J., Batbayli, M., Sørensen, N., & Born, A. P. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02807.x · Cited by 6
Genetic and Metabolic Disorders of the White Matter
Vanderver, A. L., & Wolf, N. I. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00071-8 · Cited by 7
Author response: DNA-PK is a DNA sensor for IRF-3-dependent innate immunity
Ferguson, B. J., Mansur, D. S., Peters, N., Ren, H., & Smith, G. L. (2012) · eLife · doi:10.7554/elife.00047.012 · Cited by 7
Two rare mutations in homozygosity synergize to silence TREX1 in Aicardi-Goutières syndrome
Rubin, T. S., Bernier, S., Lim, L. S. H., Salman, M. S., Leung, E., Mhanni, A. A., Marles, S. L., Greenberg, C. R., Perez, A., Sun, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1557632 · Cited by 8
Recent insights into the role of innate immunity in lupus
Robinson, L. A., & Pascual, V. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf066 · Cited by 7
ER-tethering directs TREX1 penetration of a BAF-dependent barrier at micronuclei
Chen, Y., Norman, R. M., Toufektchan, E., Luan, X., Shim, A., Rosenberg, H., Kovacs, M. T., Nichols, A., Hickling, J. H., Cifani, P., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.02.012 · Cited by 8
Primary immunodeficiency as a cause of immune-mediated kidney diseases
Zhang, C., Liang, D., & Liu, Z. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae117 · Cited by 6
Monogenic lupus – from gene to targeted therapy
Menzel, K., Novotná, K., Jeyakumar, N., Wolf, C., & Lee‐Kirsch, M. A. (2024) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-024-00181-x · Cited by 8
“Furthermore, rare TREX1 variants contribute to the genetic risk of complex SLE [19, 20].”
BackgroundSelf-citationPattern Recognition Receptors in Autoinflammation
Saavedra, V., Moghaddas, F., Latz, E., & Masters, S. L. (2019) · Springer eBooks · doi:10.1007/978-3-319-98605-0_4 · Cited by 7
Tsai, K., Lee, Y., Chen, B.-Y., Wu, L., Liang, S.-Y., Liu, M., Hung, Y., Hsu, H.-L., Chen, P.-Q., Shieh, J., et al. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.78279 · Cited by 7
“Interestingly, mutations of TREX1 and RNase H2 gene were found in SLE patients [29-31] and elevated SAMDH1 gene expression levels were found in peripheral blood from patients with paediatric-onset systemic lupus erythematosus [32].”
BackgroundSelf-citationAutoimmunity: Homeostasis of Innate Immunity Gone Awry
Park, H. J., & Atkinson, J. P. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9815-8 · Cited by 5
“In German and United Kingdom cohorts, they identified TREX1 mutations in 2% (9/417) of SLE patients [28].”
BackgroundFamily History of Autoimmune Disease in Patients with Aicardi-Goutières Syndrome
Schmidt, J., Olivieri, I., Vento, J. M., Fazzi, E. M., Gordish‐Dressman, H., Orcesi, S., & Vanderver, A. L. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/206730 · Cited by 6
“In another recently studied large cohort of SLE patient (N = 8730), mutations in TREX1 one occurred at a frequency of 0.5% [10].”
BackgroundInfluentialIntracellular Inflammatory Sensors for Foreign Invaders and Substances of Self-Origin
Jounai, N., Kobiyama, K., & Takeshita, F. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1680-7_5 · Cited by 5
Deacetylase SIRT1 modulates antiviral innate immunity and autoimmune diseases
Yu, S., Yu, H., Geng, S., Tang, R.-C., Zhang, A., Zhang, Y., Sun, X., & Zhang, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147873 · Cited by 5
Nijjar, J. S., & Smith, K. G. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00030-0 · Cited by 4
Innate immune sensing of macromolecule homeostasis
Yang, K., Jeltema, D., & Yan, N. (2024) · Advances in immunology · doi:10.1016/bs.ai.2024.03.004 · Cited by 4
Hawillo, K., Kemiha, S., & Técher, H. (2024) · Onco · doi:10.3390/onco4040022 · Cited by 4
Guo, F., Zhang, J., Gao, Y., Shu, Z., Sun, F., Ma, J., Zhou, X., Li, W., Mao, H., & Lei, X. (2024) · Angewandte Chemie · doi:10.1002/ange.202407641 · Cited by 4
Cyr, P., Fader, L. D., Burch, J. D., Pike, K. A., Sietsema, D. V., Boily, M.-O., Ciblat, S., Sgarioto, N., Skeldon, A. M., Gaudreault, S., et al. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00471 · Cited by 5
The SLE ‐associated TREX1‐P212fs mutation disrupts ER association leading to type I interferonopathy
Xu, S., Xiao, N., Du, H., Zhou, X., Huang, M., Feng, S., Hu, S., Zhang, X., Zhang, S. J., Cui, D., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202401579r · Cited by 5
“17 22 These mouse models have shown abnormalities in DNase function and ER localization of TREX1.”
Günther, C. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14357 · Cited by 4
Retinal Vasculitis: Fundamentals, Diagnostics, and Management
Boonsopon, S., & Anesi, S. D. (2021) · Siriraj Medical Journal/San Sirirat · doi:10.33192/smj.2021.64 · Cited by 4
Du, H., Kou, M., Deng, W., Zhou, X., Zhang, X., Huang, Z., Ren, B., Cai, X., Xu, S., Chen, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115188 · Cited by 4
Deficiency of Trex1 leads to spontaneous development of type 1 diabetes
Zhao, J., Su, Z.-H., Han, Q., Wang, M., Liu, X., Li, J., Huang, S.-Y., Chen, J., Li, X., Chen, X., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-023-00777-6 · Cited by 5
“Mutations in TREX1 are associated with the development of several autoimmune diseases, including Aicardi-Goutières Syndrome (AGS) [18], systemic lupus erythematosus (SLE) [19], familial chilblain lupus (FCL) [20], and retinal vasculopathy with cerebral leukodystrophy (RVCL) [21].”
BackgroundThe Innate Immune System in SLE
Elkon, K. B., & Lood, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00008-6 · Cited by 4
Deng, Y., & Tsao, B. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00004-2 · Cited by 7
The Third Man: DNA sensing as espionage in pulmonary vascular health and disease
Bryant, A. J., Pham, A. T., Gogoi, H., Mitchell, C. R., Pais, F. M., & Jin, L. (2021) · Pulmonary Circulation · doi:10.1177/2045894021996574 · Cited by 3
The story of DNase II: A stifled death‐wish leads to self‐harm
Crow, Y. J. (2010) · European Journal of Immunology · doi:10.1002/eji.201040829 · Cited by 4
The role of pattern-recognition receptors in innate immunity: update on Toll-like
Akira, S. (2010) · Cited by 4
Lee‐Kirsch, M. A., Aringer, M., & Kuhn, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7849-2_2 · Cited by 3
“Thus, rare variants of the TREX1 gene confer a high risk for developing SLE [ 12 ].”
BackgroundSelf-citationGenetic and Metabolic Disorders of the White Matter
Vanderver, A. L., & Wolf, N. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00099-0 · Cited by 6
Vester, S. K., & Vyse, T. J. (2019) · Rare diseases of the immune system · doi:10.1007/978-3-030-03934-9_1 · Cited by 4
Self-citationGünther, C., & Beissert, S. (2015) · Der Hautarzt · doi:10.1007/s00105-015-3644-7 · Cited by 4
Lo, M. S., & Tsokos, G. C. (2014) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.14.50 · Cited by 4
Perl, A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39794 · Cited by 4
Goodfield, M. J. D., Dutz, J. P., & McCourt, C. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0052 · Cited by 5
Kyttaris, V. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00016-3 · Cited by 5
Guillet, S., Lazarov, T., Jordan, N., Boisson, B., Tello‐Lafoz, M., Craddock, B. P., Zhou, T., Nishi, C., Bareja, R., Yang, H., et al. (2024) · eLife · doi:10.7554/elife.96085.2.sa0 · Cited by 3
Luo, H., Cai, Y., Shi, H., Ma, L., Zhang, S., Yung, K. K. L., & Zhou, P. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114742 · Cited by 3
Sun, Y., Zheng, J., Zhang, Y., Zhang, R., Cao, X., Liu, X., Liu, J., Weihong, D., & Zhao, M. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00801 · Cited by 3
Cytoplasmic DNA sensing boosts CD4+ T cell metabolism for inflammatory induction
Ye, J., Fu, J., Hou, H., Wang, Y., Deng, W., Hao, S., Pei, Y., Xu, J., Zheng, M., & Xiao, Y. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad021 · Cited by 4
Baglaenko, Y., Wagner, C. A., Bhoj, V. G., Brodin, P., Gershwin, M. E., Graham, D. B., Invernizzi, P., Kídd, K. K., Korsunsky, I., Levy, M., et al. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.14 · Cited by 7
Yuan, Z., Zhang, W., Jin, Z., Wang, Y., Lin, Z., Xie, Z., & Wang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33350 · Cited by 3
Vasculitis urticarial hipocomplementémica: aclaración histórica
Maldonado, J. E., & Gamarra, A. I. (2014) · Revista Colombiana de Reumatología · doi:10.1016/s0121-8123(14)70153-7 · Cited by 3
Cytokines in cutaneous lupus erythematosus
Wittmann, M., & Goodfield, M. J. D. (2011) · Expert Review of Dermatology · doi:10.1586/edm.11.39 · Cited by 3
Conséquences pathologiques d’un excès d’interféronin vivo
Lebon, P., Crow, Y. J., Casanova, J., & Gresser, I. (2019) · médecine/sciences · doi:10.1051/medsci/2019037 · Cited by 3
Myocarditis in Systemic Immune-Mediated Diseases
Caforio, A. L. P., Marcolongo, R., Baritussio, A., Leoni, L., Cheng, C., & Iliceto, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_11 · Cited by 3
Bankers, L., Miller, C. M., Liu, G., Thongkittidilok, C., Morrison, J. H., & Poeschla, E. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901421 · Cited by 2
Foddis, M., Blumenau, S., Holtgrewe, M., Paquette, K., Westra, K., Alonso, I. D. C. M. P., Macário, C., Morgadinho, A., Velon, A. G., Santo, G., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.11.013 · Cited by 3
Mendelian disorders of immunity related to an upregulation of type I interferon
Frémond, M., & Crow, Y. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00032-6 · Cited by 3
Kuhn, A., Böhm, M., & Luger, T. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10027-0 · Cited by 3
Déterminisme des pathologies auto-immunes : facteurs génétiques et environnementaux
Dieudé, P., & Dawidowicz, K. (2010) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2010.05.001 · Cited by 4
Host DNA Induced Inflammation and Autoimmune Diseases
Pandey, S., & Kawai, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-404732-7.00005-8 · Cited by 3
Vanmolkot, K. R. J., Terwindt, G. M., Frants, R. R., Haan, J., van den Maagdenberg, A., & Ferrari, M. D. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01511.x · Cited by 5
Hosseini, S. A., & Labilloy, A. (2019) · StatPearls · Cited by 4
Lupus erythematodes – ein klinisch-pathologisch heterogenes Krankheitsbild
Obermoser, G., Zelger, B. G., & Zelger, B. W. H. (2020) · Der Pathologe · doi:10.1007/s00292-020-00785-w · Cited by 3
McMahan, Z. H., & Paik, J. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1526-2_11 · Cited by 3
Pathogenesis of tissue injury in the brain in patients with systemic lupus erythematosus
Hunt, D. P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00038-6 · Cited by 4
Ritchie, C., & Li, L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.15.537029 · Cited by 3
Immunogenetics of the Ocular Anterior Segment: Lessons from Inherited Disorders
Serpen, J. Y., Armenti, S. T., & Prasov, L. (2021) · Journal of Ophthalmology · doi:10.1155/2021/6691291 · Cited by 2
“(e clinical features of SLE and its genotype-phenotype correlations remain to be fully elucidated, and the condition can be highly variable.”
InfluentialTREX1 enables viral entry in intestinal epithelia via immunity-independent control of endocytosis
Liu, X., Guo, H., Ni, F., Yang, W., Tang, Y., Xia, H., Yu, X., Zhang, L., & Wei, W. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116611 · Cited by 2
Discovery of isoindoline-2(1H)-carboxamide STING inhibitors as anti-inflammatory agents
Zhou, X., Zang, S., Yao, S., Zhou, H., Wang, X., Geng, M., Zhan, Z., Xie, Z., & Duan, W. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11424-y · Cited by 2
Rioux, B., McGlasson, S. L., Forbes, D., Reid, K. R., Klingseisen, A., Berry, J. S., Dhaun, N., Ng, W. F., Whiteley, W., & Hunt, D. P. J. (2026) · Nature Communications · doi:10.1038/s41467-025-67832-z · Cited by 2
Molecular insights for the tumor suppressor role of SPOP in prostate cancer
Yan, P., Xue, X., Hou, T., Wang, J., Jiang, W., Wang, Z., Inuzuka, H., & Wei, W. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189560 · Cited by 2
Inside Out: How Cellular Localisation Shapes cGAS Functions in Health and Disease
Wu, J., Zhou, Y., Zeng, B., Wang, Y., & Wang, C. (2026) · Immunology · doi:10.1111/imm.70133 · Cited by 2
Zhu, J., Wang, L., Lin, C., Bian, S., Luan, X., Sui, Y., Piao, L., & Zhou, W. (2026) · Immunity · doi:10.1016/j.immuni.2026.03.025 · Cited by 2
González, L. A., Ugarte-Gil, M., Pons-Estel, G., & Alarcón, G. (2023) · Lupus · doi:10.1177/09612033231169896 · Cited by 1
To cleave or not and how? The DNA exonucleases and endonucleases in immunity
Lu, M., Wu, J., Gao, Q., Jin, R., An, C., & Ma, T. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101219 · Cited by 3
“12,13,61 A common feature of these diseases is the reduced 3 0 5 0 nucleic acid exonuclease activity of the mutant TREX1.”
Prakash, P., Khodke, P., Balasubramaniam, M., Davids, B.-O., Hollis, T., Davis, J. S., Pandhare, J., Kumbhar, B. V., & Dash, C. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107438 · Cited by 2
Self-citationMouse models of type I interferonopathies
Luca, D., & Kato, H. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae187 · Cited by 2
Tever, O. K., Mentrup, T., Chinn, I. K., Ishikuma, H., Fluhrer, R., Schmitz, M., Wehner, R., Behrendt, R., Chinen, J., & Schröder, B. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05645-5 · Cited by 2
Günther, C. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14357_g · Cited by 2
Aicardi-Goutieres Syndrome-A Case Report
Liza, N. A. S., Anwar, S. S., & Kundu, G. K. (2022) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v40i2.58697 · Cited by 2
Tacke, U., & Korinthenberg, R. (2008) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-008-1882-9 · Cited by 3
Interferon and Apoptosis in Systemic Lupus Erythematosus
Daniel, N., & Brian, D. (2012) · InTech eBooks · doi:10.5772/25734 · Cited by 2
Alyamkina, E. A., Долгова, Е. В., Proskurina, A. S., Rogachev, V. A., Ostanin, A. A., Chernykh, E. R., Bogachev, S. S., & Shurdov, M. A. (2014) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2013-5-413-430 · Cited by 3
Exonuclease TREX1 also Has a Sweet Tooth
Barchet, W., & Zillinger, T. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.026 · Cited by 2
“In this context, mutations in three prime repair exonuclease 1 (TREX1) were the first identified monogenetic cause of severe lupus (Lee-Kirsch et al., 2007) as well as of the rare autoimmune diseases Aicardi Goutières syndrome and retinal vasculopathy with cerebral leukodystrophy (RVCL) (Richards…”
BackgroundSystemic lupus erythematosus genetics: what’s new?
Rhodes, B., & Vyse, T. J. (2008) · Future Rheumatology · doi:10.2217/17460816.3.2.103 · Cited by 2
“Occasional rare but highly penetrant mutations occur, such as complement C1q deficiency and the recently described variation in the TREX1 exonuclease; however, in most cases, SLE risk is likely to be determined by common variants occurring in a number of different genes [4,5].”
BackgroundSelf-citationCell Survival and Death in Rheumatic Diseases
Elkon, K. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00027-x · Cited by 4
The Innate Immune System in SLE
Bossaller, L., & Marshak‐Rothstein, A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00006-6 · Cited by 2
Crow, M. K., Kirou, K. A., & Niewold, T. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00012-8 · Cited by 2
NEGATIVE MODULATORS OF THE CGAS-STING PATHWAY
Pike, K. A., Beveridge, R. E., Cyr, P., Skeldon, A. M., Wang, L., & Burch, J. D. (2022) · Medicinal chemistry reviews · doi:10.1021/mc-2022-vol57.ch07 · Cited by 3
Metadata
- Authors
- Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., Kere, J., Pfeiffer, C., Harvey, S., Wong, A., Koskenmies, S., Hummel, O., Rohde, K., Schmidt, R. E., Dominiczak, A. F., Gahr, M., Hollis, T., Perrino, F. W., Lieberman, J., & Hübner, N.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Technische Universität Dresden (DE)
- Wake Forest University Health Sciences (US)
- Medizinische Hochschule Hannover (DE)
- Hammersmith Hospital (GB)
- Karolinska Institutet (SE)
- Klinik und Poliklinik für Dermatologie (DE)
- University of Helsinki (FI)
- University of Glasgow (GB)
- Corresponding author
- Lee, Young-Ae
- Hübner, Norbert
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-07-29
- Volume
- 39
- Issue
- 9
- Pages
- 1065-1067
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2043959346
- Semantic Scholar
- 443992a86650d6f5f9c909d94b91ccce78822316
- Cited by
- 730
- References
- 15
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 57 · 2023: 32 · 2022: 30 · 2021: 36 · 2020: 23 · 2019: 44 · 2018: 34 · 2017: 39 · 2016: 48 · 2015: 43 · 2014: 38 · 2013: 57 · 2012: 48
- FWCI
- 25.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- National Institute of Allergy and Infectious Diseases (AI45587)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREX1, systemic lupus erythematosus, 3'-5' exonuclease, Aicardi-Goutières syndrome, monoallelic variants, frameshift mutation, missense mutations, 3'UTR variant, subcellular targeting, genetic susceptibility
- MeSH terms
- Exodeoxyribonucleases, Gene Frequency, Genotype, HeLa Cells, Humans, Lupus Erythematosus, Cutaneous, Mutation, Phosphoproteins, Endosomes, Recombinant Proteins, Frameshift Mutation, Protein Structure, Tertiary, Genetic Predisposition to Disease, Mutation, Missense, 3' Untranslated Regions, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.